Minibeam Radiation Therapy for Recurrent Mucosal Melanoma: An Eye-Opening Response

We report a case of novel radiation treatment referred to as minibeam radiation therapy (MBRT) that was used to treat recurrent mucosal melanoma. The patient’s disease recurred after surgery, conventional radiation therapy, and 4 lines of systemic therapy, and then, the patient was referred to our c...

Full description

Saved in:
Bibliographic Details
Main Authors: Maddi A. Jacobson, MPAS, PA-C, Yasamin Sharifzadeh, MD, Arkadiusz Z. Dudek, MD, PhD, Svetomir N. Markovic, MD, PhD, Jeffrey E. Johnson, MD, Jonathan M. Morris, MD, Scott C. Lester, MD, Robert W. Mutter, MD, Michael P. Grams, PhD, Sean S. Park, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2542454825000517
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849416607107907584
author Maddi A. Jacobson, MPAS, PA-C
Yasamin Sharifzadeh, MD
Arkadiusz Z. Dudek, MD, PhD
Svetomir N. Markovic, MD, PhD
Jeffrey E. Johnson, MD
Jonathan M. Morris, MD
Scott C. Lester, MD
Robert W. Mutter, MD
Michael P. Grams, PhD
Sean S. Park, MD, PhD
author_facet Maddi A. Jacobson, MPAS, PA-C
Yasamin Sharifzadeh, MD
Arkadiusz Z. Dudek, MD, PhD
Svetomir N. Markovic, MD, PhD
Jeffrey E. Johnson, MD
Jonathan M. Morris, MD
Scott C. Lester, MD
Robert W. Mutter, MD
Michael P. Grams, PhD
Sean S. Park, MD, PhD
author_sort Maddi A. Jacobson, MPAS, PA-C
collection DOAJ
description We report a case of novel radiation treatment referred to as minibeam radiation therapy (MBRT) that was used to treat recurrent mucosal melanoma. The patient’s disease recurred after surgery, conventional radiation therapy, and 4 lines of systemic therapy, and then, the patient was referred to our clinic. Despite substantial disease progression after multiple prior therapies, a complete metabolic and clinical response, along with an improved quality of life and performance status, was achieved after 2 treatments of MBRT. Additionally, disease response was noted in an unirradiated abdominal metastasis. The MBRT treatments were well-tolerated, with minimal toxicity reported more than 6 months posttreatment. This case highlights the potential of MBRT as a completely novel form of radiation therapy that warrants further study.
format Article
id doaj-art-7ac159c136c941bfb5dc32dcd42b2ebd
institution Kabale University
issn 2542-4548
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series Mayo Clinic Proceedings: Innovations, Quality & Outcomes
spelling doaj-art-7ac159c136c941bfb5dc32dcd42b2ebd2025-08-20T03:33:08ZengElsevierMayo Clinic Proceedings: Innovations, Quality & Outcomes2542-45482025-08-019410064010.1016/j.mayocpiqo.2025.100640Minibeam Radiation Therapy for Recurrent Mucosal Melanoma: An Eye-Opening ResponseMaddi A. Jacobson, MPAS, PA-C0Yasamin Sharifzadeh, MD1Arkadiusz Z. Dudek, MD, PhD2Svetomir N. Markovic, MD, PhD3Jeffrey E. Johnson, MD4Jonathan M. Morris, MD5Scott C. Lester, MD6Robert W. Mutter, MD7Michael P. Grams, PhD8Sean S. Park, MD, PhD9Department of Radiation Oncology, Mayo Clinic, Rochester, MNDepartment of Radiation Oncology, Mayo Clinic, Rochester, MNDivision of Medical Oncology, Mayo Clinic, Rochester, MNDivision of Medical Oncology, Mayo Clinic, Rochester, MNDivision of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MNDepartment of Radiology, Mayo Clinic, Rochester, MNDepartment of Radiation Oncology, Mayo Clinic, Rochester, MNDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MNDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN; Correspondence: Address to Michael P. Grams, PhD, Mayo Clinic Department of Radiation Oncology, 200 1st St SW, Rochester, MN 55905.Department of Radiation Oncology, Mayo Clinic, Rochester, MNWe report a case of novel radiation treatment referred to as minibeam radiation therapy (MBRT) that was used to treat recurrent mucosal melanoma. The patient’s disease recurred after surgery, conventional radiation therapy, and 4 lines of systemic therapy, and then, the patient was referred to our clinic. Despite substantial disease progression after multiple prior therapies, a complete metabolic and clinical response, along with an improved quality of life and performance status, was achieved after 2 treatments of MBRT. Additionally, disease response was noted in an unirradiated abdominal metastasis. The MBRT treatments were well-tolerated, with minimal toxicity reported more than 6 months posttreatment. This case highlights the potential of MBRT as a completely novel form of radiation therapy that warrants further study.http://www.sciencedirect.com/science/article/pii/S2542454825000517
spellingShingle Maddi A. Jacobson, MPAS, PA-C
Yasamin Sharifzadeh, MD
Arkadiusz Z. Dudek, MD, PhD
Svetomir N. Markovic, MD, PhD
Jeffrey E. Johnson, MD
Jonathan M. Morris, MD
Scott C. Lester, MD
Robert W. Mutter, MD
Michael P. Grams, PhD
Sean S. Park, MD, PhD
Minibeam Radiation Therapy for Recurrent Mucosal Melanoma: An Eye-Opening Response
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
title Minibeam Radiation Therapy for Recurrent Mucosal Melanoma: An Eye-Opening Response
title_full Minibeam Radiation Therapy for Recurrent Mucosal Melanoma: An Eye-Opening Response
title_fullStr Minibeam Radiation Therapy for Recurrent Mucosal Melanoma: An Eye-Opening Response
title_full_unstemmed Minibeam Radiation Therapy for Recurrent Mucosal Melanoma: An Eye-Opening Response
title_short Minibeam Radiation Therapy for Recurrent Mucosal Melanoma: An Eye-Opening Response
title_sort minibeam radiation therapy for recurrent mucosal melanoma an eye opening response
url http://www.sciencedirect.com/science/article/pii/S2542454825000517
work_keys_str_mv AT maddiajacobsonmpaspac minibeamradiationtherapyforrecurrentmucosalmelanomaaneyeopeningresponse
AT yasaminsharifzadehmd minibeamradiationtherapyforrecurrentmucosalmelanomaaneyeopeningresponse
AT arkadiuszzdudekmdphd minibeamradiationtherapyforrecurrentmucosalmelanomaaneyeopeningresponse
AT svetomirnmarkovicmdphd minibeamradiationtherapyforrecurrentmucosalmelanomaaneyeopeningresponse
AT jeffreyejohnsonmd minibeamradiationtherapyforrecurrentmucosalmelanomaaneyeopeningresponse
AT jonathanmmorrismd minibeamradiationtherapyforrecurrentmucosalmelanomaaneyeopeningresponse
AT scottclestermd minibeamradiationtherapyforrecurrentmucosalmelanomaaneyeopeningresponse
AT robertwmuttermd minibeamradiationtherapyforrecurrentmucosalmelanomaaneyeopeningresponse
AT michaelpgramsphd minibeamradiationtherapyforrecurrentmucosalmelanomaaneyeopeningresponse
AT seansparkmdphd minibeamradiationtherapyforrecurrentmucosalmelanomaaneyeopeningresponse